Journal of Cancer Therapy
Vol.6 No.1(2015), Paper ID 52674, 11
pages
DOI:10.4236/jct.2015.61001
Rituximab Improves Overall Survival in Patients Treated with CODOX-M/IVAC for Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and BL (BCL-U): A Single Center Experience and Review of the Literature
A. Prica, A. Pratzer, M. Cheung, K. Thompson, E. Piliotis, N. L. Berinstein, K. Imrie, R. Pradhan, A. Vyas, Z. Ghorab, D. Good, L. Zhang, R. Buckstein
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Feinberg School of Medicine, Northwestern University, Chicago, USA
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Canada
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Canada
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Canada
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
Copyright © 2015 A. Prica, A. Pratzer, M. Cheung, K. Thompson, E. Piliotis, N. L. Berinstein, K. Imrie, R. Pradhan, A. Vyas, Z. Ghorab, D. Good, L. Zhang, R. Buckstein et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Prica, A. , Pratzer, A. , Cheung, M. , Thompson, K. , Piliotis, E. , Berinstein, N. , Imrie, K. , Pradhan, R. , Vyas, A. , Ghorab, Z. , Good, D. , Zhang, L. and Buckstein, R. (2015) Rituximab Improves Overall Survival in Patients Treated with CODOX-M/IVAC for Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and BL (BCL-U): A Single Center Experience and Review of the Literature.
Journal of Cancer Therapy,
6, 1-11. doi:
10.4236/jct.2015.61001.